Bayesian Strategies in Rare Diseases

Bayesian strategies for planning and analyzing clinical trials have become a viable choice, especially in rare diseases where drug development faces many challenges and stakeholders are interested in innovations that may help overcome them. Disease natural history and clinical outcomes occurrence an...

Descripción completa

Detalles Bibliográficos
Autores principales: Garczarek, Ursula, Muehlemann, Natalia, Richard, Frank, Yajnik, Pranav, Russek-Cohen, Estelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789883/
https://www.ncbi.nlm.nih.gov/pubmed/36566312
http://dx.doi.org/10.1007/s43441-022-00485-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789883/
https://www.ncbi.nlm.nih.gov/pubmed/36566312
http://dx.doi.org/10.1007/s43441-022-00485-y

Ejemplares similares